FACULTY
MEET OUR FACULTY
DR. ANINDITA DE
Assistant Professor
Email Id
aninditade@jssuninoida.edu.inEducation
- 2020 PhD, (Pharmaceutical Sciences), JSS College of Pharmacy, JSS Academy of Higher Education and Research
- 2011 Master in Pharmaceutics, JSS College of Pharmacy, JSS University.
- 2009 Bachelor in Pharmacy, Netaji Subhas Chandra Bose Institute of Pharmacy, West Bengal Board of Technical Education.
Research
Google scholar
ORC iDAwards & Recognition
- Best oral Presentation Award in international conference on recent advance in molecular translational in MASLD organized by Delhi Institute of Pharmaceutical Science and Research university ( govt ) ( DIPSARU) August 2025
- ICMR TB summit: Best Oral presenter, Bharat Mandapam, Delhi march 2024
- Best Post Award in Korean international Gastric Cancer conference, April 2018, Seoul, South Korea
- 10/12 CME (Continuing Medical Education) score in European Neuroendocrine Tumor Society, Germany conference, 6-8th March 2019, Spain
- Edit Pharma gold medal in M. Pharm, 2011
- Conference Coordinator INSPIR conference series 1: Regulatory pathway for Drug approval: emerging trends and Innovation, May 2, 2025
- Department of Biotechnology, Govt of India New Zealand Breast Cancer Symposium, 2017
- Korean International Gastric Cancer Week, South Korea, 2018
- JSS University, European Neuroendocrine Tumor Society conference, Spain, 2019
- Korean Society of Medical Oncology Travel, South Korea Grant, 2019
Experience
- 14 years
Publications / Key Publications
- Singh V, Vishnoi M, Jeyaprakash N, Moinuddin SQ, Anindita De, Bansal A. Development and Performance Evaluation of La2O3 Doped WC-10Co-4Cr Coatings for Enhanced Biofouling and Slurry Abrasion Resistance. Journal of Materials Research and Technology. 2025 Jul 16. Impact Factor: 6.0
- Roychowdhury P, Prajapati GK, Singh R, Gurunath P, C R, Kuppuswamy G, Anidnita De. Therapeutic Evaluation Punica granatum Peel Powder for the Ailment of Inflammatory Bowel Disorder in NCM460 Cell Line and in Albino Rats. Pharmaceutics. 2025 Jun 27;17(7):843. Impact Factor: 5.0
- Swati Sharma,, Geetanjali B. Gone, Parikshit Roychowdhury, Hyung Sik Kim, Sang Jeon Chung, Gowthmarajan Kuppusamy, and Anindita De, Photodynamic and sonodynamic therapy synergy: mechanistic insights and cellular responses against glioblastoma multiforme, Journal of Drug Targeting , 2025. Impact Factor: 4.3
- Roychowdhury P, Thirugnanasambandham I, Anindita De, Gobinath M, Khanra S, Karri VV, Bhuyan NR, Kuppusamy G. A DR4, DR5 Targeting Conjugated TRAIL Treatment for Colorectal Carcinogenesis: A Way to Future?. Pharmaceutical Sciences. 2025(1):3-21. Impact Factor: 1.6
- Kang JH, Lee OH, Anindita De, Ko YT. Molecular engineering of tetraphenylethene/thiophene-based donor/π-bridge units to enhance the AIE effect and boost the oxygen-independent type-I ROS generation. Journal of Photochemistry and Photobiology A: Chemistry. 2024 Aug 1;453:115635. Impact Factor: 5.6
- Anindita De, Jun-Pil Jee , Young-Joon Park , Why Perfluorocarbon nanoparticles encounter bottlenecks in clinical translation despite promising oxygen carriers?, European Journal of Pharmaceutics and Biopharmaceutics, 2024 Impact Factor: 5.0
- Anindita De, Ji Hee Kang, Sauraj, O.Hyun Lee, Young Tag Ko, Optimizing Long-Term Stability of siRNA using Thermoassemble Ionizable reverse pluronic-Bcl2 Micelleplexes, International Journal of Biological Macromolecules, 264(2), 2024. Impact Factor: 8.2
- Anindita De, Young Tag Ko, Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out, Expert opinion of Drug Delivery, 20(1), 2023. Impact Factor: 6.6
- Anindita De, Ashish Wadhwani, Parikshit Roychowdhury , Gowthamarajan Kuppusamy, WZB117 Decorated Metformin-Carboxymethyl Chitosan Nanoparticles for Targeting Breast Cancer Metabolism, Polymers 15 (4): 976., 2023 Impact Factor: 5.0
- Kang KM, Jeon SW, De A, Hong TS, Park YJ. A randomized, open-label, single-dose, crossover study of the comparative bioavailability of EPA and DHA in a novel liquid crystalline nanoparticle-based formulation of ω-3 acid ethyl Ester versus Omacor® soft capsule among healthy adults. International Journal of Molecular Sciences. 2023 Dec 6;24(24):17201 Impact Factor: 5.3
Areas of Specialization / Research Interests
- Cancer cell metabolism targeted drug delivery
- Computerized DoE based drug delivery
- Ionizable lipid and polymeric nanoparticles for crossing BBB and cancer cells barriers
Projects / Grants
- Post Doctoral research Grant: Basic Science Research Program of the National Research Foundation of Korea (NRF) and funded by the Ministry of Science and ICT (NRF-2020R1A2B5B01001719 and RS-2023-00243851) (2021-2023) (Total cost 22.8 lakhs)
- Doctoral Research Grant: Senior Research Fellow, Indian Council of Medical Research, India (2018-2019) (Total cost 8.6 lakhs)
- Junior Research Fellow, JSS Academy of Technical Education and Research (2017-2018)
- Department of Biotechnology, Govt of India New Zealand Breast Cancer Symposium, 2017
- Korean International Gastric Cancer Week, South Korea, 2018
- JSS University, European Neuroendocrine Tumor Society conference, , Spain,2019
- Korean Society of Medical Oncology Travel, South Korea Grant, 2019
Courses Taught
- Undergraduate courses Physical Pharmaceutics, Industrial Pharmacy, Novel Drug Delivery system
- Postgraduate courses Drug Delivery system, Computer Aided Drug Delivery, Cosmetics and cosmeceuticals, Good Laboratory Practice
- PhD Courses Research Ethics
Conference / Workshops Attended / Invited Talks
- Conference: 25
- Workshops: 03
- Invited talk: 02
Professional Memberships / Responsibilities
- Registered Pharmacist, Pharmacy Council of India, West Bengal Branch
- Life time member of Indian Pharmaceutical Association
- Life time Member of Association of Pharmaceutical Teachers of India
- Life Time member of European Neuroendocrine Tumor Society (ENTS), Indian Chapter
- Drug Design, Development and Therapy, Dove medical Press
Supervision
- M.Pharm – 04
- PhD- 03. (03 Ongoing)